Skip to content

Clinical trials

Observational Central Nervous System Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Phase: Observational Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20052
20061
20071
20081
20112
20141
20154
20163
20172
20182
20191
20211
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting5
Enrolling by invitation2
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tammie L. S. Benzinger, MD, PhD4
Bracco Diagnostics, Inc2
National Institute of Allergy and Infectious Diseases (NIAID)2
University of Florida2
Washington University School of Medicine2
Alzheimer's Disease and Related Disorders Association, Inc1
BlueRock Therapeutics1
CAMC Health System1
Epilepsy Foundation of America1
Lifegraph Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases26
Brain Diseases16
Nervous System Diseases13
Alzheimer Disease10
Neurodegenerative Diseases9
Dementia7
Cognitive Dysfunction6
Tauopathies5
Brain Diseases, Metabolic, Inborn3
Central Nervous System Neoplasms3

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.